Medical treatment of children with hemangiomas and its limitations;Hämangiomtherapie im kindesalter: Medikamentöse therapiemöglichkeiten und ihre Grenzen

Handchirurgie Mikrochirurgie Plastische Chirurgie

Volumn 41, Issue 2, 2009, Pages 78-82

  Haxhija, E Q ^a   Lackner, H ^a   Hollwarth M E ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

drugs; hemangioma; treatment

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; IMMUNOLOGIC FACTOR; PREDNISONE; VINCRISTINE;

ARTICLE; CHILD; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; HEMANGIOMA; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; NEWBORN; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SKIN TUMOR; SOFT TISSUE TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEMANGIOMA; HUMANS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; PREDNISONE; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; VINCRISTINE;

EID: 67849087290     PISSN: 07221819     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038772     Document Type: Article

References (29)

1. Barlow C F., Priebe C J., Mulliken J B. et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998 132 527-530
2. Boon L M., MacDonald D M., Mulliken J B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999 104 1616-1623
3. Bruckner A L., Frieden I J. Hemangiomas of infancy. J Am Acad Dermatol 2003 48 477-493
4. Chang E, Boyd A, Nelson C C. et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997 19 237-244
5. Chiller K G., Passaro D, Frieden I J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002 138 1567-1576
6. Dienhart S M., Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001 27 475-485
7. Dubois J, Hershon L, Carmant L et al. Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr 1999 135 782-785
8. Enjolras O, Wassef M, Mazoyer E et al. Infants with Kasabach-Merritt syndrome do not have true hemangiomas. J Pediatr 1997 130 631-640
9. Fawcett S L., Grant I, Hall P N. et al. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004 57 168-171
10. Frieden I J., Haggstrom A N., Drolet B A. et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 79, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005 22 383-406
11. Gottschling S, Schneider G, Meyer S et al. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer 2006 46 239-242
12. Greene A K., Rogers G F., Mulliken J B. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 2004 113 53-60
13. Greinwald J H. Jr, Burke D K., Bonthius D J. et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999 125 21-27
14. Hasan Q, Tan S T., Gush J et al. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 2000 105 117-120
15. Hasan Q, Tan S T., Xu B et al. Effects of five commonly used glucocorticoids on haemangioma in vitro. Clin Exp Pharmacol Physiol 2003 30 140-144
16. Hawkins D B., Crockett D M., Kahlstrom E J. et al. Corticosteroid management of airway hemangiomas: long-term follow-up. Laryngoscope 1984 94 633-637
17. Hurvitz C H., Alkalay A L., Sloninsky L et al. Cyclophosphamide therapy in life-threatening vascular tumors. J Pediatr 1986 109 360-363
18. Lackner H, Kerbl R, Schwinger W et al. Systemische Therapie lebensbedrohlicher Hämangiome des Kindesalters. Paediatr Paedol 1997 32 123-127 (Pubitemid 27381193)
19. Metry D. Update on hemangiomas of infancy. Curr Opin Pediatr 2004 16 373-377
20. Metry D W. Potential complications of segmental hemangiomas of infancy. Semin Cutan Med Surg 2004 23 107-115
21. Michaud A P., Bauman N M., Burke D K. et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004 114 1231-1236
22. Perez J, Pardo J, Gomez C. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995 333 69-69
23. Perez J, Pardo J, Gomez C. Vincristine an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 2002 41 197-199
24. Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 1996 128 141-146
25. Sarkar M, Mulliken J B., Kozakewich H P. et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997 100 1377-1386
26. Singh R K., Gutman M, Bucana C D. et al. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995 92 4562-4566
27. Sovinz P, Urban C, Hausegger K. Life-threatening hemangiomatosis of the liver in an infant: multimodal therapy including cyclophosphamide and secondary acute myeloid leukemia. Pediatr Blood Cancer 2006 47 972-973
28. White C W., Sondheimer H M., Crouch E C. et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989 320 1197-1200
29. Zarem H A., Edgerton M T. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967 39 76-83